TNSN99051A1 - Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation - Google Patents

Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation

Info

Publication number
TNSN99051A1
TNSN99051A1 TNTNSN99051A TNSN99051A TNSN99051A1 TN SN99051 A1 TNSN99051 A1 TN SN99051A1 TN TNSN99051 A TNTNSN99051 A TN TNSN99051A TN SN99051 A TNSN99051 A TN SN99051A TN SN99051 A1 TNSN99051 A1 TN SN99051A1
Authority
TN
Tunisia
Prior art keywords
preparation
compounds
matrix metalloproteinase
phenoxyphenylsulfonyl
halides
Prior art date
Application number
TNTNSN99051A
Other languages
English (en)
French (fr)
Inventor
Michael Hawkins Joel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN99051A1 publication Critical patent/TNSN99051A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C301/00Esters of sulfurous acid
    • C07C301/02Esters of sulfurous acid having sulfite groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/75Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TNTNSN99051A 1998-04-10 1999-04-07 Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation TNSN99051A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8139398P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
TNSN99051A1 true TNSN99051A1 (fr) 2005-11-10

Family

ID=22163859

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99051A TNSN99051A1 (fr) 1998-04-10 1999-04-07 Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation

Country Status (42)

Country Link
US (2) US6118016A (hu)
EP (1) EP0949246B1 (hu)
JP (1) JP3694419B2 (hu)
KR (1) KR100329901B1 (hu)
CN (1) CN1238329A (hu)
AP (1) AP1155A (hu)
AR (1) AR016205A1 (hu)
AT (1) ATE233729T1 (hu)
AU (1) AU758297B2 (hu)
BG (1) BG103321A (hu)
BR (1) BR9902041A (hu)
CA (1) CA2268679C (hu)
CO (1) CO4810300A1 (hu)
DE (1) DE69905633T2 (hu)
DK (1) DK0949246T3 (hu)
DZ (1) DZ2755A1 (hu)
EA (1) EA001756B1 (hu)
ES (1) ES2192021T3 (hu)
GT (1) GT199900044A (hu)
HR (1) HRP990107B1 (hu)
HU (1) HU221635B1 (hu)
ID (1) ID23645A (hu)
IL (1) IL129330A (hu)
IN (1) IN191233B (hu)
IS (1) IS5020A (hu)
MA (1) MA24834A1 (hu)
NO (1) NO991679L (hu)
NZ (1) NZ335106A (hu)
OA (1) OA11032A (hu)
PA (1) PA8469801A1 (hu)
PE (1) PE20000416A1 (hu)
PL (1) PL332452A1 (hu)
SG (1) SG75169A1 (hu)
SI (1) SI0949246T1 (hu)
SK (1) SK44999A3 (hu)
TN (1) TNSN99051A1 (hu)
TR (1) TR199900757A2 (hu)
TW (1) TW539664B (hu)
UA (1) UA59373C2 (hu)
UY (1) UY25472A1 (hu)
YU (1) YU18299A (hu)
ZA (1) ZA992628B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
EP1511488B1 (en) * 2002-06-12 2013-05-22 Symphony Evolution, Inc. Human adam-10 inhibitors
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP2590951B1 (en) 2010-07-09 2015-01-07 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE844004C (de) * 1944-08-06 1952-07-14 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Sulfonsaeureestern
US4032506A (en) * 1973-12-28 1977-06-28 General Electric Company Flame retardant polycarbonate composition
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5340489A (en) * 1992-06-05 1994-08-23 The Dow Chemical Company Aryl arenesulfonates and a method of lubrication using the aryl arenesulfonates
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CN1228083A (zh) * 1996-08-23 1999-09-08 美国辉瑞有限公司 芳基磺酰氨基异羟肟酸衍生物
NZ336840A (en) * 1997-02-03 2001-01-26 Pfizer Prod Inc Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases
WO1998050348A1 (en) * 1997-05-09 1998-11-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
NZ502309A (en) * 1997-08-08 2002-02-01 Pfizer Prod Inc Aryloxyarylsulfonylamino hydroxamic acid derivatives and pharmaceutical use
ES2176913T3 (es) * 1997-08-08 2002-12-01 Pfizer Prod Inc Derivados de acidos arilsulfonilaminohidroxamicos.
PA8469401A1 (es) * 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
BR9902041A (pt) 2000-05-02
US6118016A (en) 2000-09-12
EP0949246B1 (en) 2003-03-05
DE69905633D1 (de) 2003-04-10
HUP9901042A3 (en) 2000-06-28
AR016205A1 (es) 2001-06-20
CN1238329A (zh) 1999-12-15
IN191233B (hu) 2003-10-11
NO991679L (no) 1999-10-11
IL129330A0 (en) 2000-02-17
BG103321A (en) 2001-08-31
SG75169A1 (en) 2000-09-19
MA24834A1 (fr) 1999-12-31
CO4810300A1 (es) 1999-06-30
ATE233729T1 (de) 2003-03-15
US20010011143A1 (en) 2001-08-02
HU9901042D0 (en) 1999-06-28
AP9901509A0 (en) 1999-06-30
AU2369299A (en) 1999-10-21
ES2192021T3 (es) 2003-09-16
ZA992628B (en) 2000-10-09
PA8469801A1 (es) 2000-09-29
EA001756B1 (ru) 2001-08-27
AU758297B2 (en) 2003-03-20
HRP990107A2 (en) 2000-02-29
HU221635B1 (hu) 2002-12-28
DK0949246T3 (da) 2003-04-07
UA59373C2 (uk) 2003-09-15
DZ2755A1 (fr) 2003-09-15
IS5020A (is) 1999-10-11
EA199900282A2 (ru) 1999-10-28
KR19990082980A (ko) 1999-11-25
TR199900757A3 (tr) 1999-11-22
NZ335106A (en) 2000-09-29
KR100329901B1 (ko) 2002-03-22
PL332452A1 (en) 1999-10-11
SI0949246T1 (en) 2003-06-30
IL129330A (en) 2003-12-10
JPH11322704A (ja) 1999-11-24
UY25472A1 (es) 1999-11-17
NO991679D0 (no) 1999-04-09
HUP9901042A2 (hu) 1999-12-28
GT199900044A (es) 2000-09-14
TW539664B (en) 2003-07-01
AP1155A (en) 2003-06-30
JP3694419B2 (ja) 2005-09-14
CA2268679A1 (en) 1999-10-10
PE20000416A1 (es) 2000-05-24
OA11032A (en) 2002-02-06
SK44999A3 (en) 2000-09-12
HRP990107B1 (en) 2003-10-31
DE69905633T2 (de) 2003-11-06
ID23645A (id) 2000-05-04
CA2268679C (en) 2004-07-27
EP0949246A1 (en) 1999-10-13
TR199900757A2 (xx) 1999-11-22
EA199900282A3 (ru) 2000-04-24
YU18299A (sh) 2002-11-15

Similar Documents

Publication Publication Date Title
PT874808E (pt) Inibidores bifenil-hidroxamato de metaloproteinases de matriz
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
ATE232536T1 (de) N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-
TNSN00121A1 (fr) Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26901A1 (fr) Nouvelle composition pharmaceutique
FI971412A (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
TNSN01017A1 (fr) Compositions comprenant un antibiotique azalide, et procedes pour leur preparation
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE207349T1 (de) Thip zur behandlung von schlafstörungen
HUP9902083A3 (en) Sulfonamide inhibitors of matrix metalloproteinases
ATE219058T1 (de) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase- inhibitoren
DE69939165D1 (de) N,n-disubstituierte amide welche die bindung von integrinen an ihre rezeptoren hemmen
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00230A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2, 3,4-tetrahydroquinoleine
TNSN97078A1 (fr) Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
EE200000093A (et) Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks
FR2824477B1 (fr) Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
DK0946502T3 (da) Sulfonamidinhibitorer for det interleukin-1beta-omdannende enzym
IT1277904B1 (it) Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego
TNSN99051A1 (fr) Halogenures de phenoxyphenylsulfonyle et procede pour leur preparation
BR9713207A (pt) Derivados de 3-mercaptoacetilamino-1,5-substituìdo-2-oxo-azepan uteis como inibidores de metaloproteinase de matriz
TNSN02038A1 (fr) Composes conjugues de pregabaline et de lactose nouveaux, et compositions les contenant
DZ3512A1 (fr) Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de médicaments